Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgel in Type 2 Diabetic Males With Hypogonadism
NCT00350701Phase 4Completed
- Sponsor
- University at Buffalo
- Start
- Jul 2006
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of AndroForte in Hypogonadism (3 arms), sponsored by University at Buffalo. Primary endpoint: Relative Nuclear Factor kB Activity at 8 weeks. Started Jul 2006; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00350701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350701.